New York Obesity and Nutrition Research Center
8
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
12.5%
1 terminated/withdrawn out of 8 trials
87.5%
+1.0% vs industry average
0%
0 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Encouraging Healthy Food Shopping and Eating Behaviors by Price Reduction: A Community Supermarket Study
Role: lead
fMRI and Appetite-Related Hormones Pre and Post Obesity Surgery
Role: lead
Brain Activation in Response to Appetitive Cues Pre- and Post- Bariatric Surgery
Role: lead
Novel Mediators of the Lipodystrophy and Metabolic Consequences of Cushing's Disease
Role: collaborator
fMRI and Ghlrein in Obesity and Binge Eating Disorder
Role: lead
Effect of Different Fiber Breakfasts on Appetite and Weight Change in Overweight Subjects
Role: lead
Appetite Hormones in Binge Eating Disorder
Role: lead
Studies of Biological Changes Related to Weight Loss After Gastric Bypass Surgery
Role: collaborator
All 8 trials loaded